New Weekly HIV Treatment Option Shows Comparable Efficacy to Daily Regimens
15/09/2026
Switching to a weekly oral investigational regimen of islatravir and lenacapavir (Sunlenca) was just as effective as daily oral standard-of-care
La proporción de mujeres que nunca se han sometido a pruebas de cáncer cervical ha aumentado más del 5% por…
Read more →
Switching to a weekly oral investigational regimen of islatravir and lenacapavir (Sunlenca) was just as effective as daily oral standard-of-care
Las semanas pasadas, sociedades médicas líderes realizaron una tarea tanto inusual como indispensable: La American Academy of Family Physicians, la
Introducción La Academia Americana de Pediatría (AAP) ha actualizado sus recomendaciones para la prevención del virus sincitial respiratorio (RSV) y
While trust in doctors as a source of information about cancer remained high during and after the COVID-19 pandemic, trust
Resultados del estudio Nirmatrelvir-ritonavir (Paxlovid) no demostró ser más eficaz que un placebo para aliviar los síntomas del long COVID,